Skip to main content

Cambridge Innovation Capital — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

52
Companies
$1.8B
Total invested
$33.8M
Avg. check
29
Industries
Biotechnology 13Therapeutics 9Health Care 8Medical 6Artificial Intelligence (AI) 5Software 5+23 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 25–48 of 52
Unlikely AI
September 2022

Unlikely AI is a talented group that is approaching artificial intelligence from a daring, fresh angle.

Artificial Intelligence (AI) · London$20.3M Seed
Sense Biodetection
November 2021

Sense Biodetection is a molecular diagnostics company .

Health Care · Abingdon$15.0M Series B
Gyroscope Therapeutics
November 2021

Gyroscope Therapeutics is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye.

Biotechnology · Stevenage$60.0M Corporate Round
PetMedix
September 2021

PetMedix is a pet therapeutics startup.

Biotechnology · Cambridge$37.2M Series B
BeyondMath
February 2026

BeyondMath develops an AI simulation platform for optimizing complex physical designs without supercomputers or physical prototypes.

Analytics · Cambridge$10.0M Seed
Salience Labs
September 2025

Salience Labs provides photonic switch technology and optical networking solutions tailored for AI infrastructure.

Artificial Intelligence (AI) · OxfordSeries Unknown
Sortera Bio
June 2025

Sortera Bio operates as a biotechnology company.

Biotechnology · Cambridge$10.2M Pre-Seed
Mosaic Therapeutics
April 2025

Mosaic Therapeutics is an oncology therapeutics company that develops targeted combination therapies for cancer patients.

Biotechnology · CambridgeCorporate Round
TRIMTECH Therapeutics
March 2025

TRIMTECH Therapeutics treats inflammatory and persistent CNS conditions by focusing on the elimination of harmful proteins.

Biotechnology · Cambridge$31.0M Seed
Cambridge GaN Devices
February 2025

Cambridge GaN Devices is a semiconductor company focused on developing GaN power devices aimed at creating greener electronics.

Electronics · Cambridge$32.0M Series C
Forefront RF
November 2024

Forefront RF is a fabless semiconductor company.

Semiconductor · Cambridge$20.8M Series A
Epitopea
October 2024

Epitopea is a transatlantic cancer immunotherapeutics company.

Biotechnology · Cambridge$31.0M Seed
Microbiotica
August 2024

Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers.

Biotechnology · CambridgeSeries Unknown
Riverlane
August 2024

Riverlane develops software solutions to harness the power of quantum computers for practical applications.

Computer · Cambridge$75.0M Series C
Secondmind
November 2023

Machine learning for automotive innovators

Artificial Intelligence (AI) · Cambridge$16.0M Series Unknown
Phosphor AI
August 2023

Phosphor AI provides personalized AI tutoring solutions for secondary education.

Education · Cambridge$2.5M Seed
Complement Therapeutics
April 2023

Complement Therapeutics operates as a preclinical stage company.

Biotechnology · London$78.7M Series A
Seldon
March 2023

An AI and machine learning deployment, management and observability platform.

AI Infrastructure · London$20.0M Series B
Storm Therapeutics
December 2022

Targeting pathways that modify RNA to deliver novel cancer therapeutics

Biotechnology · Cambridge$30.0M Series B
Carrick Therapeutics
December 2022

Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.

Biotechnology · Dublin$60.0M Series C
Exvastat
May 2020

Exvastat is an innovative, preclinical-stage pharmaceutical company.

Biotechnology · Cambridge$3.9M Grant
AudioTelligence
March 2020

AudioTelligence delivers real-time audio processing technology for the enhancement of automatic speech recognition (ASR) systems.

Audio · Cambridge$1.9M Seed
PolyProx
March 2020

PolyProx Therapeutics is a developer of a novel class of drug intended to provide new therapies for cancer treatment.

Biotechnology · Cambridge$1.3M Seed
Z Factor
May 2017

Z Factor Limited is a drug discovery company to identify and develop therapeutic agents to treat alpha-1-antitrypsin deficiency

Biotechnology · Cambridge$9.0M Series A

Where Cambridge Innovation Capital invests

Biotechnology13
Therapeutics9
Health Care8
Medical6
Artificial Intelligence (AI)5
Software5

About Cambridge Innovation Capital's portfolio

How many companies has Cambridge Innovation Capital invested in?▸

Cambridge Innovation Capital has invested in 52 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Cambridge Innovation Capital invest in?▸

Cambridge Innovation Capital's top investment sectors include Biotechnology, Therapeutics, Health Care, Medical, Artificial Intelligence (AI). The firm invests across 29 different industry categories.

What is Cambridge Innovation Capital's largest investment?▸

Among tracked funding rounds, Complement Therapeutics received $78.7M in a Series A round. Cambridge Innovation Capital's total known invested capital is $1.8B.

What is the average investment size for Cambridge Innovation Capital?▸

Cambridge Innovation Capital's average investment size is $33.8M across its portfolio of 52 companies.

What are Cambridge Innovation Capital's most recent investments?▸

Recent Cambridge Innovation Capital portfolio additions include Unlikely AI, Sense Biodetection, Gyroscope Therapeutics, PetMedix, BeyondMath. These companies were founded in 2020 or later.

Reach the founders behind these 52 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →